» Articles » PMID: 14729947

Physical and Functional Interactions of the Arf Tumor Suppressor Protein with Nucleophosmin/B23

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2004 Jan 20
PMID 14729947
Citations 170
Authors
Affiliations
Soon will be listed here.
Abstract

The Arf tumor suppressor inhibits cell cycle progression through both p53-dependent and p53-independent mechanisms, including interference with rRNA processing. Using tandem-affinity-tagged p19(Arf), we purified Arf-associated proteins from mouse NIH 3T3 fibroblasts undergoing cell cycle arrest. Tagged p19(Arf) associated with nucleolar and ribosomal proteins, including nucleophosmin/B23 (NPM), a protein thought to foster the maturation of preribosomal particles. NPM is an abundant protein, only a minor fraction of which binds to p19(Arf); however, a significant proportion of p19(Arf) associates with NPM. The interaction between p19(Arf) and NPM requires amino acid sequences at the Arf amino terminus, which are also required for Mdm2 binding, as well as the central acidic domain of NPM and an adjacent segment that regulates NPM oligomerization. The interaction between p19(Arf) and NPM occurs in primary mouse embryonic fibroblasts, including those lacking both Mdm2 and p53. In an NIH 3T3 derivative cell line (MT-Arf) engineered to conditionally express an Arf transgene, induced p19(Arf) associates with NPM and colocalizes with it in high-molecular-weight complexes (2 to 5 MDa). An NPM mutant lacking its carboxyl-terminal nucleic acid-binding domain oligomerizes with endogenous NPM, inhibits p19(Arf) from entering into 2- to 5-MDa particles, and overrides the ability of p19(Arf) to retard rRNA processing.

Citing Articles

Functions of the native NPM1 protein and its leukemic mutant.

Falini B, Sorcini D, Perriello V, Sportoletti P Leukemia. 2024; 39(2):276-290.

PMID: 39690184 DOI: 10.1038/s41375-024-02476-4.


p14 forms meso-scale assemblies upon phase separation with NPM1.

Gibbs E, Miao Q, Ferrolino M, Bajpai R, Hassan A, Phillips A Nat Commun. 2024; 15(1):9531.

PMID: 39528457 PMC: 11555371. DOI: 10.1038/s41467-024-53904-z.


NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression.

Wang X, Chai Y, Quan Y, Wang J, Song J, Zhou W J Hematol Oncol. 2024; 17(1):97.

PMID: 39402629 PMC: 11479574. DOI: 10.1186/s13045-024-01618-6.


Novel circular RNA hsa_circ_0036683 suppresses proliferation and migration by mediating the miR-4664-3p/CDK2AP2 axis in non-small cell lung cancer.

Liu R, Zhang H, Xin J, Xie S, Jiao F, Li Y Thorac Cancer. 2024; 15(27):1929-1945.

PMID: 39113208 PMC: 11462936. DOI: 10.1111/1759-7714.15396.


Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression.

Zhou Y, Nakajima R, Shirasawa M, Fikriyanti M, Zhao L, Iwanaga R Biology (Basel). 2023; 12(12).

PMID: 38132337 PMC: 10740672. DOI: 10.3390/biology12121511.


References
1.
Okuwaki M, Tsujimoto M, Nagata K . The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype. Mol Biol Cell. 2002; 13(6):2016-30. PMC: 117621. DOI: 10.1091/mbc.02-03-0036. View

2.
Dundr M, Olson M . Partially processed pre-rRNA is preserved in association with processing components in nucleolus-derived foci during mitosis. Mol Biol Cell. 1998; 9(9):2407-22. PMC: 25507. DOI: 10.1091/mbc.9.9.2407. View

3.
Colombo E, Marine J, Danovi D, Falini B, Pelicci P . Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol. 2002; 4(7):529-33. DOI: 10.1038/ncb814. View

4.
Nissan T, Bassler J, Petfalski E, Tollervey D, Hurt E . 60S pre-ribosome formation viewed from assembly in the nucleolus until export to the cytoplasm. EMBO J. 2002; 21(20):5539-47. PMC: 129079. DOI: 10.1093/emboj/cdf547. View

5.
Zhao L, Samuels T, Winckler S, Korgaonkar C, Tompkins V, Horne M . Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. Mol Cancer Res. 2003; 1(3):195-206. View